» Articles » PMID: 27173746

Adherence to Long-term Anticoagulation Treatment, What is Known and What the Future Might Hold

Overview
Journal Br J Haematol
Specialty Hematology
Date 2016 May 14
PMID 27173746
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non-adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non-adherence to long-term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM-B (capability, opportunity, motivation and behaviour) psychological model of non-adherence, we present the available evidence, not only in terms of describing the extent of the non-adherence problem, but also describing why patients do not adhere, offering theory-driven and evidence-based solutions to improve long-term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.

Citing Articles

D-Dimer in Acute Mesenteric Venous Thrombosis: A Prospective Case-Control International Multicenter Study.

Acosta S, Reintam Blaser A, Nuzzo A, Soltanzadeh-Naderi Y, Starkopf J, Forbes A Biomark Insights. 2024; 19:11772719241296631.

PMID: 39600492 PMC: 11590162. DOI: 10.1177/11772719241296631.


Barriers to medication adherence in sickle cell disease: A comprehensive theory-based evaluation using the COM-B model.

King K, Cai S, Barrera L, Reddy P, Heneghan M, Badawy S Pediatr Blood Cancer. 2023; :e30440.

PMID: 37243925 PMC: 10679470. DOI: 10.1002/pbc.30440.


Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism.

Kang H, Dietrich E, Huang P, Lo-Ciganic W, DeRemer C, Park H Clin Transl Sci. 2023; 16(6):946-954.

PMID: 36891985 PMC: 10264957. DOI: 10.1111/cts.13510.


Cilioretinal artery occlusion in antiphospholipid syndrome and the decision to anticoagulate.

Delavar A, Baxter S BMJ Case Rep. 2022; 15(11).

PMID: 36384882 PMC: 9670929. DOI: 10.1136/bcr-2022-249509.


Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry.

Schulz A, Herrmann E, Ott O, Lindhoff-Last E J Clin Med. 2022; 11(16).

PMID: 36013082 PMC: 9409774. DOI: 10.3390/jcm11164845.